| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 56 | 2022 | 1284 | 4.810 |
Why?
|
| Embryo Transfer | 25 | 2023 | 510 | 4.800 |
Why?
|
| Cryopreservation | 24 | 2023 | 670 | 4.190 |
Why?
|
| Infertility | 20 | 2022 | 655 | 3.590 |
Why?
|
| Oocytes | 25 | 2022 | 1187 | 2.600 |
Why?
|
| Pregnancy Rate | 23 | 2023 | 643 | 1.800 |
Why?
|
| Birth Rate | 4 | 2023 | 170 | 1.770 |
Why?
|
| Cryoprotective Agents | 8 | 2020 | 112 | 1.630 |
Why?
|
| Live Birth | 13 | 2023 | 512 | 1.610 |
Why?
|
| Embryo Implantation | 9 | 2018 | 272 | 1.390 |
Why?
|
| Pregnancy Outcome | 19 | 2020 | 2795 | 1.340 |
Why?
|
| Trehalose | 7 | 2016 | 88 | 1.270 |
Why?
|
| Ovarian Follicle | 6 | 2016 | 247 | 1.240 |
Why?
|
| Blastocyst | 5 | 2020 | 424 | 1.100 |
Why?
|
| Infertility, Female | 10 | 2017 | 787 | 1.070 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 5 | 2012 | 53 | 1.030 |
Why?
|
| Reproductive Techniques, Assisted | 10 | 2022 | 482 | 0.990 |
Why?
|
| Oocyte Retrieval | 7 | 2020 | 161 | 0.970 |
Why?
|
| Fertility | 9 | 2018 | 781 | 0.930 |
Why?
|
| Ovulation Induction | 8 | 2015 | 274 | 0.850 |
Why?
|
| Pregnancy | 60 | 2023 | 29144 | 0.840 |
Why?
|
| Sperm Motility | 6 | 2017 | 253 | 0.790 |
Why?
|
| Fetal Resorption | 1 | 2020 | 17 | 0.750 |
Why?
|
| Infertility, Male | 8 | 2021 | 409 | 0.740 |
Why?
|
| Reproductive Medicine | 1 | 2022 | 108 | 0.730 |
Why?
|
| Radiation Dosage | 17 | 2017 | 1928 | 0.720 |
Why?
|
| Spermatozoa | 8 | 2016 | 625 | 0.720 |
Why?
|
| Premature Birth | 3 | 2022 | 1721 | 0.720 |
Why?
|
| Progesterone | 2 | 2023 | 776 | 0.650 |
Why?
|
| Abortion, Spontaneous | 3 | 2020 | 544 | 0.620 |
Why?
|
| Peromyscus | 1 | 2016 | 18 | 0.570 |
Why?
|
| Semen Preservation | 1 | 2016 | 35 | 0.570 |
Why?
|
| Embryonic Development | 5 | 2013 | 711 | 0.540 |
Why?
|
| Estradiol | 8 | 2015 | 2020 | 0.510 |
Why?
|
| Fertilization | 6 | 2021 | 196 | 0.480 |
Why?
|
| Thinness | 1 | 2017 | 480 | 0.470 |
Why?
|
| Syringes | 1 | 2013 | 56 | 0.470 |
Why?
|
| Tomography, X-Ray Computed | 17 | 2017 | 20129 | 0.450 |
Why?
|
| Paternal Exposure | 4 | 2017 | 89 | 0.450 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2015 | 402 | 0.440 |
Why?
|
| Pregnancy, Ectopic | 1 | 2013 | 141 | 0.420 |
Why?
|
| Radiography, Abdominal | 8 | 2010 | 537 | 0.420 |
Why?
|
| Placenta | 4 | 2022 | 1698 | 0.420 |
Why?
|
| Radiometry | 7 | 2008 | 800 | 0.410 |
Why?
|
| Sucrose | 3 | 2016 | 164 | 0.410 |
Why?
|
| Ovary | 5 | 2010 | 981 | 0.400 |
Why?
|
| Chorionic Gonadotropin | 2 | 2012 | 477 | 0.380 |
Why?
|
| Microinjections | 5 | 2005 | 327 | 0.380 |
Why?
|
| Sperm Count | 7 | 2017 | 216 | 0.370 |
Why?
|
| Placenta Diseases | 3 | 2022 | 199 | 0.360 |
Why?
|
| Sperm Injections, Intracytoplasmic | 4 | 2018 | 160 | 0.360 |
Why?
|
| Female | 98 | 2023 | 380194 | 0.350 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 1678 | 0.350 |
Why?
|
| Adult | 78 | 2021 | 214055 | 0.340 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2008 | 249 | 0.340 |
Why?
|
| Soy Foods | 3 | 2015 | 48 | 0.340 |
Why?
|
| Birth Weight | 4 | 2022 | 2069 | 0.330 |
Why?
|
| Body Mass Index | 9 | 2017 | 12720 | 0.330 |
Why?
|
| Retrospective Studies | 30 | 2023 | 77449 | 0.330 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2008 | 1184 | 0.320 |
Why?
|
| Professional Practice | 1 | 2010 | 326 | 0.320 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2010 | 255 | 0.320 |
Why?
|
| Follicle Stimulating Hormone | 5 | 2007 | 744 | 0.320 |
Why?
|
| Caffeine | 3 | 2017 | 699 | 0.320 |
Why?
|
| Twinning, Monozygotic | 1 | 2007 | 17 | 0.310 |
Why?
|
| Embryo, Mammalian | 6 | 2019 | 1701 | 0.300 |
Why?
|
| Logistic Models | 8 | 2020 | 13408 | 0.290 |
Why?
|
| Twins | 2 | 2011 | 339 | 0.290 |
Why?
|
| Flame Retardants | 2 | 2017 | 87 | 0.290 |
Why?
|
| Tomography, Spiral Computed | 6 | 2005 | 280 | 0.290 |
Why?
|
| Pre-Eclampsia | 2 | 2012 | 1200 | 0.280 |
Why?
|
| Zygote | 3 | 2003 | 116 | 0.280 |
Why?
|
| Environmental Pollutants | 4 | 2017 | 1179 | 0.270 |
Why?
|
| Humans | 114 | 2023 | 744343 | 0.270 |
Why?
|
| Tomography Scanners, X-Ray Computed | 3 | 2004 | 168 | 0.270 |
Why?
|
| Semen | 6 | 2012 | 316 | 0.260 |
Why?
|
| Stress, Psychological | 1 | 2020 | 4245 | 0.250 |
Why?
|
| Prophase | 2 | 1994 | 17 | 0.250 |
Why?
|
| Parabens | 2 | 2015 | 108 | 0.250 |
Why?
|
| Telemedicine | 1 | 2022 | 2872 | 0.240 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2008 | 450 | 0.240 |
Why?
|
| Polyploidy | 3 | 1998 | 114 | 0.230 |
Why?
|
| Pandemics | 2 | 2022 | 8388 | 0.230 |
Why?
|
| Treatment Outcome | 20 | 2021 | 63114 | 0.230 |
Why?
|
| Phantoms, Imaging | 9 | 2012 | 2480 | 0.230 |
Why?
|
| Attitude to Health | 1 | 2012 | 2052 | 0.220 |
Why?
|
| Semen Analysis | 7 | 2017 | 204 | 0.220 |
Why?
|
| Birth Intervals | 1 | 2022 | 51 | 0.210 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 438 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Radiation Protection | 5 | 2009 | 419 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2016 | 378 | 0.210 |
Why?
|
| Pelvis | 4 | 2010 | 730 | 0.200 |
Why?
|
| Gonadotropins | 4 | 2015 | 241 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 3158 | 0.200 |
Why?
|
| Cell Survival | 6 | 2005 | 5882 | 0.200 |
Why?
|
| Carbohydrate Metabolism | 1 | 2002 | 264 | 0.200 |
Why?
|
| Menopause | 2 | 2008 | 1626 | 0.200 |
Why?
|
| Infant, Newborn | 8 | 2022 | 25625 | 0.190 |
Why?
|
| Freezing | 2 | 2016 | 303 | 0.190 |
Why?
|
| Odds Ratio | 4 | 2018 | 9849 | 0.190 |
Why?
|
| Eating | 3 | 2018 | 1536 | 0.190 |
Why?
|
| Body Burden | 4 | 2009 | 158 | 0.190 |
Why?
|
| Fallopian Tubes | 2 | 2011 | 182 | 0.190 |
Why?
|
| Vitrification | 1 | 2020 | 56 | 0.180 |
Why?
|
| Cytoskeleton | 3 | 2004 | 1185 | 0.180 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 12245 | 0.180 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3508 | 0.180 |
Why?
|
| Radiation Injuries | 4 | 2009 | 1180 | 0.180 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2012 | 440 | 0.170 |
Why?
|
| Radiographic Image Enhancement | 5 | 2008 | 885 | 0.170 |
Why?
|
| Prospective Studies | 22 | 2022 | 53288 | 0.170 |
Why?
|
| Cumulus Cells | 1 | 2018 | 20 | 0.170 |
Why?
|
| Oligosaccharides | 2 | 2016 | 414 | 0.170 |
Why?
|
| Phenols | 2 | 2015 | 497 | 0.170 |
Why?
|
| Lasers | 2 | 2008 | 952 | 0.170 |
Why?
|
| Academic Medical Centers | 4 | 2018 | 2759 | 0.160 |
Why?
|
| Obesity | 4 | 2017 | 12745 | 0.160 |
Why?
|
| Cells, Immobilized | 1 | 2018 | 36 | 0.160 |
Why?
|
| Folic Acid | 2 | 2015 | 1300 | 0.160 |
Why?
|
| Ovarian Cysts | 1 | 1999 | 115 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2009 | 1901 | 0.160 |
Why?
|
| Body Size | 3 | 2010 | 461 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 850 | 0.150 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 1997 | 54 | 0.150 |
Why?
|
| Diethylstilbestrol | 1 | 1997 | 93 | 0.150 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2018 | 428 | 0.150 |
Why?
|
| Risk Factors | 13 | 2020 | 72290 | 0.150 |
Why?
|
| Embryo Culture Techniques | 1 | 2017 | 80 | 0.150 |
Why?
|
| 3-O-Methylglucose | 1 | 2016 | 37 | 0.150 |
Why?
|
| Pesticide Residues | 1 | 2018 | 95 | 0.140 |
Why?
|
| Raffinose | 1 | 2016 | 52 | 0.140 |
Why?
|
| Preimplantation Diagnosis | 1 | 2019 | 151 | 0.140 |
Why?
|
| Placenta Accreta | 1 | 2020 | 225 | 0.140 |
Why?
|
| Radiation Monitoring | 1 | 2017 | 98 | 0.140 |
Why?
|
| Radiography, Thoracic | 4 | 2005 | 1265 | 0.140 |
Why?
|
| Health Care Costs | 1 | 2009 | 3209 | 0.140 |
Why?
|
| Biotechnology | 1 | 2018 | 281 | 0.130 |
Why?
|
| Ovulation | 1 | 2016 | 189 | 0.130 |
Why?
|
| Learning Curve | 1 | 2017 | 208 | 0.130 |
Why?
|
| Osmolar Concentration | 3 | 2010 | 683 | 0.130 |
Why?
|
| Aneuploidy | 1 | 2019 | 530 | 0.130 |
Why?
|
| Preconception Care | 1 | 2016 | 134 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2019 | 600 | 0.130 |
Why?
|
| Fetal Mortality | 1 | 2014 | 19 | 0.130 |
Why?
|
| Biomimetics | 1 | 2016 | 172 | 0.130 |
Why?
|
| Functional Food | 1 | 2014 | 20 | 0.120 |
Why?
|
| Fishes | 2 | 2015 | 569 | 0.120 |
Why?
|
| Seafood | 2 | 2015 | 384 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2017 | 3966 | 0.120 |
Why?
|
| Leuprolide | 1 | 1996 | 321 | 0.120 |
Why?
|
| Inhibins | 3 | 2000 | 211 | 0.120 |
Why?
|
| X-Rays | 2 | 2008 | 301 | 0.120 |
Why?
|
| Male | 48 | 2021 | 350118 | 0.120 |
Why?
|
| Time Factors | 6 | 2018 | 40075 | 0.120 |
Why?
|
| Gestational Age | 2 | 2020 | 3493 | 0.120 |
Why?
|
| Meat Products | 1 | 2014 | 99 | 0.120 |
Why?
|
| Tissue Preservation | 1 | 1994 | 182 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 3923 | 0.110 |
Why?
|
| Endometriosis | 2 | 1998 | 839 | 0.110 |
Why?
|
| Glucose | 3 | 2016 | 4397 | 0.110 |
Why?
|
| Phthalic Acids | 1 | 2017 | 436 | 0.110 |
Why?
|
| Suction | 1 | 2013 | 267 | 0.110 |
Why?
|
| Isoflavones | 2 | 2015 | 139 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 527 | 0.110 |
Why?
|
| Mercury | 1 | 2015 | 285 | 0.110 |
Why?
|
| Microfluidics | 1 | 2018 | 662 | 0.110 |
Why?
|
| Meat | 1 | 2015 | 592 | 0.100 |
Why?
|
| Fruit | 1 | 2018 | 1142 | 0.100 |
Why?
|
| Vegetables | 1 | 2018 | 1182 | 0.100 |
Why?
|
| Cohort Studies | 12 | 2017 | 40561 | 0.100 |
Why?
|
| Hair | 1 | 2015 | 483 | 0.100 |
Why?
|
| Animals | 18 | 2020 | 168757 | 0.100 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2010 | 30 | 0.100 |
Why?
|
| Posthumous Conception | 1 | 2010 | 11 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 906 | 0.090 |
Why?
|
| Artifacts | 8 | 2012 | 1904 | 0.090 |
Why?
|
| Equipment Design | 5 | 2018 | 3582 | 0.090 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 1996 | 1205 | 0.090 |
Why?
|
| Mice, Inbred DBA | 3 | 2008 | 642 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2012 | 8949 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2017 | 961 | 0.090 |
Why?
|
| Third-Party Consent | 1 | 2010 | 64 | 0.090 |
Why?
|
| Iohexol | 1 | 2010 | 196 | 0.090 |
Why?
|
| Phase Transition | 1 | 2009 | 74 | 0.090 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 133 | 0.090 |
Why?
|
| Propylene Glycols | 1 | 2009 | 92 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 25043 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2453 | 0.090 |
Why?
|
| Trans Fatty Acids | 1 | 2010 | 153 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 4042 | 0.090 |
Why?
|
| Prolactinoma | 1 | 2010 | 113 | 0.090 |
Why?
|
| Linear Models | 6 | 2017 | 5952 | 0.080 |
Why?
|
| Granulosa Cells | 2 | 2000 | 120 | 0.080 |
Why?
|
| Hyperprolactinemia | 1 | 2010 | 129 | 0.080 |
Why?
|
| Mice | 13 | 2020 | 81183 | 0.080 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2008 | 94 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 242 | 0.080 |
Why?
|
| Middle Aged | 26 | 2021 | 213383 | 0.080 |
Why?
|
| Gravidity | 1 | 2008 | 51 | 0.080 |
Why?
|
| Nitrogen | 1 | 2009 | 344 | 0.080 |
Why?
|
| Uterus | 1 | 1992 | 711 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 791 | 0.070 |
Why?
|
| Endocrine Disruptors | 1 | 2010 | 237 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1827 | 0.070 |
Why?
|
| Estrogens | 2 | 2012 | 1566 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1856 | 0.070 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 498 | 0.070 |
Why?
|
| Metaphase | 3 | 1998 | 151 | 0.070 |
Why?
|
| Glycoproteins | 4 | 2000 | 2263 | 0.070 |
Why?
|
| Overweight | 2 | 2014 | 2371 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2861 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2019 | 3444 | 0.070 |
Why?
|
| Immobilization | 1 | 2007 | 236 | 0.070 |
Why?
|
| Growth Substances | 2 | 1998 | 784 | 0.070 |
Why?
|
| Anxiety | 1 | 2020 | 4297 | 0.070 |
Why?
|
| Massachusetts | 4 | 2021 | 8663 | 0.070 |
Why?
|
| Hormones | 2 | 2000 | 889 | 0.060 |
Why?
|
| Electrochemistry | 1 | 2005 | 145 | 0.060 |
Why?
|
| Noise | 1 | 2007 | 279 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1997 | 2408 | 0.060 |
Why?
|
| Fever | 1 | 2012 | 1616 | 0.060 |
Why?
|
| Parity | 1 | 2008 | 929 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2009 | 712 | 0.060 |
Why?
|
| Decision Making | 1 | 2019 | 3887 | 0.060 |
Why?
|
| Risk | 1 | 2017 | 9687 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2011 | 828 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15076 | 0.060 |
Why?
|
| Technology, Radiologic | 1 | 2004 | 163 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2292 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 390 | 0.060 |
Why?
|
| Young Adult | 9 | 2021 | 56430 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2012 | 2017 | 0.060 |
Why?
|
| Posture | 1 | 2008 | 958 | 0.060 |
Why?
|
| Chorionic Villi | 1 | 2003 | 51 | 0.060 |
Why?
|
| HEPES | 1 | 2003 | 10 | 0.060 |
Why?
|
| Family Characteristics | 2 | 2021 | 1000 | 0.060 |
Why?
|
| Uterine Hemorrhage | 2 | 1997 | 255 | 0.060 |
Why?
|
| Tromethamine | 1 | 2003 | 31 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6365 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3188 | 0.050 |
Why?
|
| Ovulation Detection | 1 | 2002 | 5 | 0.050 |
Why?
|
| Osmosis | 1 | 2002 | 113 | 0.050 |
Why?
|
| Sperm Immobilizing Agents | 1 | 2002 | 2 | 0.050 |
Why?
|
| Zona Pellucida | 1 | 2002 | 18 | 0.050 |
Why?
|
| Follicular Fluid | 2 | 2000 | 87 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 203 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2010 | 1253 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2014 | 3297 | 0.050 |
Why?
|
| Chromatography, Gas | 2 | 2012 | 156 | 0.050 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 723 | 0.050 |
Why?
|
| Men | 1 | 2021 | 63 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1572 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1345 | 0.050 |
Why?
|
| Receptors, Growth Factor | 2 | 2000 | 334 | 0.050 |
Why?
|
| Boston | 4 | 2017 | 9313 | 0.050 |
Why?
|
| Pregnancy, Multiple | 1 | 2022 | 217 | 0.050 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2000 | 25 | 0.050 |
Why?
|
| Weight Loss | 1 | 2012 | 2622 | 0.050 |
Why?
|
| Unnecessary Procedures | 1 | 2004 | 432 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2008 | 21827 | 0.050 |
Why?
|
| Depression | 1 | 2020 | 7766 | 0.050 |
Why?
|
| Adolescent | 10 | 2018 | 85781 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2002 | 394 | 0.050 |
Why?
|
| DNA Damage | 1 | 2010 | 2432 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2008 | 5102 | 0.040 |
Why?
|
| Radiography | 3 | 2010 | 7023 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2004 | 547 | 0.040 |
Why?
|
| Nafarelin | 1 | 1998 | 27 | 0.040 |
Why?
|
| Body Weight | 4 | 2012 | 4669 | 0.040 |
Why?
|
| Placenta Previa | 1 | 2020 | 117 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2011 | 3690 | 0.040 |
Why?
|
| Microscopy, Interference | 1 | 1998 | 33 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2014 | 2971 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 1996 | 919 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2266 | 0.040 |
Why?
|
| Receptors, LHRH | 1 | 1999 | 160 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2013 | 7729 | 0.040 |
Why?
|
| Povidone | 1 | 1998 | 33 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2002 | 783 | 0.040 |
Why?
|
| Menotropins | 1 | 1998 | 45 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2010 | 8324 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1998 | 313 | 0.040 |
Why?
|
| Reference Standards | 1 | 2002 | 1025 | 0.040 |
Why?
|
| Optical Devices | 1 | 2018 | 37 | 0.040 |
Why?
|
| Electrophoresis | 1 | 2018 | 240 | 0.040 |
Why?
|
| Oils | 1 | 2018 | 63 | 0.040 |
Why?
|
| Temperature | 1 | 2004 | 2206 | 0.040 |
Why?
|
| Chromosomes | 2 | 1998 | 596 | 0.040 |
Why?
|
| Emulsions | 1 | 2018 | 156 | 0.040 |
Why?
|
| Cell Aggregation | 1 | 2018 | 244 | 0.040 |
Why?
|
| United States | 3 | 2017 | 69872 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 196 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 1998 | 241 | 0.040 |
Why?
|
| Contrast Media | 1 | 2010 | 5300 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 1387 | 0.040 |
Why?
|
| Follistatin | 4 | 2000 | 141 | 0.040 |
Why?
|
| Urinalysis | 2 | 2015 | 369 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 1998 | 213 | 0.040 |
Why?
|
| Reference Values | 2 | 2014 | 4982 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 1998 | 277 | 0.040 |
Why?
|
| Seasons | 1 | 2003 | 1493 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 5391 | 0.040 |
Why?
|
| Teriparatide | 1 | 1998 | 225 | 0.030 |
Why?
|
| Head | 1 | 2002 | 880 | 0.030 |
Why?
|
| Hysteroscopy | 1 | 1997 | 102 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 1998 | 2020 | 0.030 |
Why?
|
| Physical Examination | 1 | 2002 | 1237 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 19905 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3589 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2002 | 1462 | 0.030 |
Why?
|
| Uterine Diseases | 1 | 1997 | 135 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2013 | 4644 | 0.030 |
Why?
|
| Relative Biological Effectiveness | 2 | 2008 | 323 | 0.030 |
Why?
|
| Aged | 16 | 2010 | 163280 | 0.030 |
Why?
|
| Follicular Phase | 1 | 1996 | 153 | 0.030 |
Why?
|
| Menstrual Cycle | 2 | 1996 | 551 | 0.030 |
Why?
|
| Poultry | 1 | 2015 | 82 | 0.030 |
Why?
|
| Pectinidae | 1 | 2015 | 5 | 0.030 |
Why?
|
| Software | 2 | 2008 | 4443 | 0.030 |
Why?
|
| Food Handling | 1 | 2015 | 145 | 0.030 |
Why?
|
| Carbonated Beverages | 1 | 2016 | 214 | 0.030 |
Why?
|
| Endocrine Glands | 1 | 1995 | 103 | 0.030 |
Why?
|
| Tea | 1 | 2016 | 275 | 0.030 |
Why?
|
| Hysterectomy | 2 | 1998 | 927 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2008 | 6459 | 0.030 |
Why?
|
| Shellfish | 1 | 2014 | 38 | 0.030 |
Why?
|
| Diet Records | 1 | 2016 | 425 | 0.030 |
Why?
|
| Endometrium | 1 | 1997 | 424 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2003 | 2240 | 0.030 |
Why?
|
| Pediatrics | 1 | 2009 | 3475 | 0.030 |
Why?
|
| Hydatidiform Mole | 1 | 1996 | 279 | 0.030 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1997 | 370 | 0.030 |
Why?
|
| Random Allocation | 2 | 2011 | 2429 | 0.030 |
Why?
|
| Prognosis | 2 | 2010 | 29063 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2014 | 262 | 0.030 |
Why?
|
| Endosonography | 1 | 1997 | 610 | 0.030 |
Why?
|
| Aged, 80 and over | 9 | 2010 | 57776 | 0.030 |
Why?
|
| Diet | 3 | 2016 | 7939 | 0.030 |
Why?
|
| Gamete Intrafallopian Transfer | 1 | 1992 | 27 | 0.030 |
Why?
|
| Reproductive Control Agents | 1 | 2012 | 7 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2373 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 601 | 0.030 |
Why?
|
| Microtubules | 1 | 1998 | 1090 | 0.030 |
Why?
|
| Steroids | 1 | 1997 | 930 | 0.030 |
Why?
|
| Coffee | 1 | 2016 | 578 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2018 | 19229 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2020 | 1365 | 0.020 |
Why?
|
| Risk Assessment | 5 | 2014 | 23338 | 0.020 |
Why?
|
| Water | 1 | 2018 | 1395 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2015 | 749 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2015 | 1173 | 0.020 |
Why?
|
| Age Factors | 2 | 2014 | 18370 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1998 | 2699 | 0.020 |
Why?
|
| Beverages | 1 | 2016 | 820 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 1414 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 2645 | 0.020 |
Why?
|
| Oligospermia | 1 | 2010 | 59 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2014 | 4933 | 0.020 |
Why?
|
| Ethics Committees, Clinical | 1 | 2010 | 56 | 0.020 |
Why?
|
| Heart | 1 | 2004 | 4467 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2000 | 1796 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 13881 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 35136 | 0.020 |
Why?
|
| Activin Receptors | 2 | 2000 | 43 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1681 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 898 | 0.020 |
Why?
|
| Reproductive Health Services | 1 | 2010 | 80 | 0.020 |
Why?
|
| Insemination, Artificial | 1 | 2010 | 98 | 0.020 |
Why?
|
| Cell Size | 1 | 2011 | 643 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 41006 | 0.020 |
Why?
|
| Neoplasms | 1 | 1998 | 21683 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 3396 | 0.020 |
Why?
|
| Osteoporosis | 1 | 1998 | 1580 | 0.020 |
Why?
|
| Observer Variation | 2 | 2005 | 2593 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 392 | 0.020 |
Why?
|
| Activins | 2 | 2000 | 208 | 0.020 |
Why?
|
| Child | 4 | 2021 | 77709 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39050 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2010 | 186 | 0.020 |
Why?
|
| Prolactin | 1 | 2010 | 669 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2001 | 5985 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1530 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2000 | 13033 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2011 | 694 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2009 | 548 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1998 | 2541 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 599 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7913 | 0.020 |
Why?
|
| Bone Density | 1 | 1998 | 3468 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 35421 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2010 | 845 | 0.010 |
Why?
|
| Prevalence | 2 | 2012 | 15226 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2012 | 1809 | 0.010 |
Why?
|
| Aging | 1 | 2003 | 8664 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 2004 | 292 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 933 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1998 | 4034 | 0.010 |
Why?
|
| Pelvic Neoplasms | 1 | 2004 | 254 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2011 | 3748 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1912 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 2838 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5078 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1998 | 6364 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1022 | 0.010 |
Why?
|
| Acetabulum | 1 | 2004 | 525 | 0.010 |
Why?
|
| Metals | 1 | 2005 | 719 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2010 | 1470 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8642 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2004 | 14722 | 0.010 |
Why?
|
| Incidental Findings | 1 | 2004 | 689 | 0.010 |
Why?
|
| Comorbidity | 1 | 2013 | 10388 | 0.010 |
Why?
|
| Liver | 2 | 2004 | 7474 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 2005 | 917 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2886 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2557 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10397 | 0.010 |
Why?
|
| Abdomen | 1 | 2004 | 1118 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6196 | 0.010 |
Why?
|
| Colloids | 1 | 1998 | 136 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 13989 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2376 | 0.010 |
Why?
|
| Life Style | 1 | 2009 | 3835 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1998 | 440 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15540 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1997 | 588 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2010 | 4234 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 1998 | 575 | 0.010 |
Why?
|
| Thoracic Neoplasms | 1 | 1997 | 268 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1998 | 13102 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1950 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1998 | 792 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2004 | 2921 | 0.010 |
Why?
|
| Actins | 1 | 2000 | 2121 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1997 | 1641 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1996 | 1539 | 0.010 |
Why?
|
| Progestins | 1 | 1993 | 306 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 795 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 2505 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1993 | 564 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12959 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 4409 | 0.000 |
Why?
|
| Postmenopause | 1 | 1995 | 2461 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1997 | 2708 | 0.000 |
Why?
|
| Recurrence | 1 | 1996 | 8340 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 11031 | 0.000 |
Why?
|
| Inflammation | 1 | 2003 | 10638 | 0.000 |
Why?
|
| Models, Biological | 1 | 1996 | 9583 | 0.000 |
Why?
|